Kevin D. Brandt
2022 - Xtant Medical Holdings
In 2022, Kevin D. Brandt earned a total compensation of $778.5K as Chief Commercial Officer at Xtant Medical Holdings, a 16% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $144,005 |
|---|---|
| Salary | $415,000 |
| Stock Awards | $213,241 |
| Other | $6,250 |
| Total | $778,496 |
Brandt received $415K in salary, accounting for 53% of the total pay in 2022.
Brandt also received $144K in non-equity incentive plan, $213.2K in stock awards and $6.3K in other compensation.
Rankings
In 2022, Kevin D. Brandt's compensation ranked 3,483rd out of 5,501 executives tracked by ExecPay. In other words, Brandt earned more than 36.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,483 out of 5,501 | 37th |
Division Manufacturing | 1,968 out of 2,980 | 34th |
Major group Chemicals And Allied Products | 931 out of 1,335 | 30th |
Industry group Drugs | 869 out of 1,238 | 30th |
Industry Biological Products, Except Diagnostic Substances | 213 out of 287 | 26th |
Source: SEC filing on June 7, 2023.
Brandt's colleagues
We found two more compensation records of executives who worked with Kevin D. Brandt at Xtant Medical Holdings in 2022.
News
Xtant Medical Holdings CEO Sean Browne's 2022 pay jumps 28% to $1.1M
June 7, 2023
Xtant Medical Holdings CFO Greg Jensen's 2021 pay rises 11% to $955K
September 20, 2022
Xtant Medical Holdings CEO Sean Browne's 2020 pay jumps 146% to $4.5M
June 14, 2021
Xtant Medical Holdings CEO Carl O'Connell's 2018 pay jumps 224% to $1.8M
September 20, 2019